News

The Aotearoa New Zealand Government is contemplating allowing sales of oral nicotine and oral tobacco products as smoking cessation aids.

Click here to read about the impacts of repealing Aotearoa's world-leading legislation.

In this modelling study, published in the New Zealand Medical Journal, the ASPIRE2025 and BODE3 research groups found that to achieve the New Zealand Government’s Smokefree 2025 Goal (a b

This opinion piece, written by the co-Directors of ASPIRE2025, was published today in the Otago Daily Times.

This recently published article in BMJ Open considers the decline in adolescent smoking in New Zealand. See the full article here:

Major tobacco companies have presented a vision of a smokefree world, where smoking prevalence has fallen to minimal levels.  This goal has much in common with national tobacco endgame goals a

The National Institute for Health Innovation (NIHI), University of Auckland and ASPIRE2025, University of Otago are delighted to announce there will be three inaugural awards presented at the upcom

In our recently published work, Estimating the effect of a potential policy to restrict tobacco retail availability in New Zealand, we studied the impact of the NZ Government preventing n

This study looks at the impact of the NZ Government preventing new retail outlets from selling tobacco from 2020, while allowing existing retail outlets to continue selling it until they closed or

The New Zealand Ministry of Health is currently using a consulting firm EY (formerly Ernst & Young) to research the impacts of tobacco taxation, despite EY’s work locally and internationally fo